Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05027373
Status:
UNKNOWN
Last Update Posted:
2021-08-30
First Post:
2021-08-17
Brief Title:
Safety Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Periodic Fever Syndrome |
| Systemic Juvenile Idiopathic Arthritis |
Keywords: